Quantitative MRI data acquired from patients with locally advanced breast cancer are used to calibrate a biophysical, reaction–diffusion mathematical model to predict response to neoadjuvant therapy on an individual patient basis.
- Angela M. Jarrett
- Anum S. Kazerouni
- Thomas E. Yankeelov